Eliminating industry representatives on advisory committees may be a small price to settle HHS Secretary Robert F. Kennedy Jr.'s concerns about conflicts of interest at the FDA. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
